Effect of tape stripping and adjuvants on immune response after intradermal DNA electroporation

Pharmaceutical Research

Volumn 26, Issue 7, 2009, Pages 1745-1751

  Vandermeulen, Gaëlle ^a   Daugimont, Liévin ^a   Richiardi, Hervé ^a   Vanderhaeghen, Marie Lise ^a   Lecouturier, Nathalie ^a   Ucakar, Bernard ^a   Préat, Véronique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Adjuvant; DNA vaccine; Electroporation; Skin

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HYALURONIDASE; IMIQUIMOD; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; LUCIFERASE; OVALBUMIN; PHOSPHORYL LIPID A; PLASMID DNA;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DELIVERY SYSTEM; ELECTROPORATION; FEMALE; HUMORAL IMMUNITY; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; AMINOQUINOLINES; ANIMALS; ANTIBODY FORMATION; ELECTROPORATION; FEMALE; HYALURONOGLUCOSAMINIDASE; IMMUNIZATION; IMMUNOGLOBULIN G; LIPID A; LUCIFERASES; MICE; MICE, INBRED BALB C; OVALBUMIN; PLASMIDS; VACCINES, DNA;

EID: 67349207093     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-9885-3     Document Type: Article

References (42)

1. C Debenedictis S Joubeh G Zhang M Barria RF Ghohestani 2001 Immune functions of the skin Clin Dermatol. 19 573 585
2. M Cemazar G Sersa 2007 Electrotransfer of therapeutic molecules into tissues Curr Opin Mol Ther. 9 554 562
3. N Pavselj V Preat 2005 DNA electrotransfer into the skin using a combination of one high- and one low-voltage pulse J Control Release. 106 407 415
4. JJ Drabick J Glasspool-Malone A King RW Malone 2001 Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization Mol Ther. 3 249 255
5. J Glasspool-Malone S Somiari JJ Drabick RW Malone 2000 Efficient nonviral cutaneous transfection Mol Ther. 2 140 146
6. G Vandermeulen E Staes ML Vanderhaeghen MF Bureau D Scherman V Preat 2007 Optimisation of intradermal DNA electrotransfer for immunisation J Control Release. 124 81 87
7. S Pedron-Mazoyer J Plouet L Hellaudais J Teissie M Golzio 2007 New anti angiogenesis developments through electro-immunization: optimization by in vivo optical imaging of intradermal electro gene transfer Biochim Biophys Acta. 1770 137 142
8. B Guy 2007 The perfect mix: recent progress in adjuvant research Nat Rev Microbiol. 5 505 517
9. DL Lodmell NB Ray JT Ulrich LC Ewalt 2000 DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL) Vaccine 18 1059 1066
10. WW Zhang G Matlashewski 2008 Immunization with a Toll-like receptor 7 and/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB/c mice Infect Immun. 76 3777 3783
11. JM McMahon E Signori KE Wells VM Fazio DJ Wells 2001 Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase-increased expression with reduced muscle damage Gene Ther. 8 1264 1270
12. DI Mummert A Takashima L Ellinger ME Mummert 2003 Involvement of hyaluronan in epidermal Langerhans cell maturation and migration in vivo J Dermatol Sci. 33 91 97
13. ME Mummert 2005 Immunologic roles of hyaluronan Immunol Res. 31 189 206
14. CC Termeer J Hennies U Voith T Ahrens JM Weiss P Prehm JC Simon 2000 Oligosaccharides of hyaluronan are potent activators of dendritic cells J Immunol. 165 1863 1870
15. V Voelcker C Gebhardt M Averbeck A Saalbach V Wolf F Weih 2008 Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4 Exp Dermatol. 17 100 107
16. N Novak CF Yu T Bieber JP Allam 2008 Toll-like receptor 7 agonists and skin Drug News Perspect. 21 158 165
17. AA Gaspari 2007 Mechanism of action and other potential roles of an immune response modifier Cutis 79 36 45
18. D Johnston JC Bystryn 2006 Topical imiquimod is a potent adjuvant to a weakly-immunogenic protein prototype vaccine Vaccine 24 1958 1965
19. DH Dockrell GR Kinghorn 2001 Imiquimod and resiquimod as novel immunomodulators J Antimicrob Chemother. 48 751 755
20. K Caglar C Aybay H Ataoglu 2005 Effect of monophosphoryl lipid A on antibody response to diphtheria toxin and its subunits APMIS 113 256 263
21. LC Freytag JD Clements 2005 Mucosal adjuvants Vaccine 23 1804 1813
22. M Martin SM Michalek J Katz 2003 Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A Infect Immun. 71 2498 2507
23. JP McAleer AT Vella 2008 Understanding how lipopolysaccharide impacts CD4 T-cell immunity Crit Rev Immunol. 28 281 299
24. R Kahlon Y Hu CH Orteu A Kifayet JD Trudeau R Tan JP Dutz 2003 Optimization of epicutaneous immunization for the induction of CTL Vaccine 21 2890 2899
25. J Strid R Callard S Strobel 2006 Epicutaneous immunization converts subsequent and established antigen-specific T helper type 1 (Th1) to Th2-type responses Immunology 119 27 35
26. J Inoue Y Aramaki 2007 Toll-like receptor-9 expression induced by tape-stripping triggers on effective immune response with CpG- oligodeoxynucleotides Vaccine 25 1007 1013
27. L Liu X Zhou J Shi X Xie Z Yuan 2003 Toll-like receptor-9 induced by physical trauma mediates release of cytokines following exposure to CpG motif in mouse skin Immunology 110 341 347
28. C Termeer F Benedix J Sleeman C Fieber U Voith T Ahrens 2002 Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4 J Exp Med. 195 99 111
29. C Bloquel C Trollet E Pradines J Seguin D Scherman MF Bureau 2006 Optical imaging of luminescence for in vivo quantification of gene electrotransfer in mouse muscle and knee BMC Biotechnol. 6 16
30. P Forg HP von W Dalemans V Schirrmacher 1998 Superiority of the ear pinna over muscle tissue as site for DNA vaccination Gene Ther. 5 789 797
31. MJ McCluskie CL Brazolot Millan RA Gramzinski HL Robinson JC Santoro JT Fuller 1999 Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates Mol Med. 5 287 300
32. Vandermeulen G, Daugimont L, Préat V. DNA transfer in the skin. In Walters KA, Roberts MS, editors. Dermatologic, cosmeceutic, and cosmetic development: therapeutic and novel approaches. New York, London: Informa; 2008, p. 537-55.
33. R Weiss S Scheiblhofer J Freund F Ferreira I Livey J Thalhamer 2002 Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccines Vaccine 20 3148 3154
34. X Zhou L Zheng L Liu L Xiang Z Yuan 2003 T helper 2 immunity to hepatitis B surface antigen primed by gene-gun-mediated DNA vaccination can be shifted towards T helper 1 immunity by codelivery of CpG motif-containing oligodeoxynucleotides Scand J Immunol. 58 350 357
35. LA Hirao L Wu AS Khan A Satishchandran R Draghia-Akli DB Weiner 2008 Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques Vaccine 26 440 448
36. W Jiang CF Reich DS Pisetsky 2006 In vitro assay of immunostimulatory activities of plasmid vectors Methods Mol Med. 127 55 70
37. C Coban S Koyama F Takeshita S Akira KJ Ishii 2008 Molecular and cellular mechanisms of DNA vaccines Hum Vaccin. 4 453 456
38. D Sawamura R Abe M Goto M Akiyama H Hemmi S Akira H Shimizu 2005 Direct injection of plasmid DNA into the skin induces dermatitis by activation of monocytes through toll-like receptor 9 J Gene Med. 7 664 671
39. E Gronevik I Mathiesen T Lomo 2005 Early events of electroporation- mediated intramuscular DNA vaccination potentiate Th1-directed immune responses J Gene Med. 7 1246 1254
40. AK Zuber A Brave G Engstrom B Zuber K Ljungberg M Fredriksson 2004 Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA Vaccine 22 1791 1798
41. CD Partidos S Muller 2005 Decision-making at the surface of the intact or barrier disrupted skin: potential applications for vaccination or therapy Cell Mol Life Sci. 62 1418 1424
42. DM Frerichs LR Ellingsworth SA Frech DC Flyer CP Villar J Yu 2008 Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch Vaccine 26 2782 2787